aiqbench analysis
Researchers at Cleveland Clinic and IBM Quantum have demonstrated that their Q-CHIPP framework improves neoantigen prediction accuracy by 6% using a hybrid classical-quantum approach on noisy hardware. By integrating MHC binding models with T-cell recognition, this work addresses the critical challenge of training quantum neural networks effectively despite current device limitations. The study establishes a scalable foundation for applying Quantum Convolutional Neural Networks to complex biomedical modeling problems where data is scarce.
Cleveland Clinic & IBM Quantum Advance Neoantigen Prediction With Q-CHIPP
Researchers at the Cleveland Clinic and IBM Quantum developed Q-CHIPP, a new quantum neural network for predicting neoantigens.
A collaboration between the Cleveland Clinic and IBM Quantum reports a 6% increase in the accuracy of cancer neoantigen prediction using quantum computing, even with limited training data. Published July 24 in Science Advances, the research introduces Quantum Convolutional HLA Immunogenic Peptide Prediction, or Q-CHIPP, a new framework integrating MHC binding and T-cell recognition. Researchers state that current quantum use cases are limited by quantum hardware and the difficulty of identifying problems that classical computers cannot easily address, framing Q-CHIPP as an attempt to…
Excerpt shown under the publisher's RSS terms · 84 words · full text and figures are on the publisher's site
Related coverage
Cleveland Clinic and IBM Develop Quantum Machine Learning Model for Cancer Neoantigen Prediction
Quantum Computing Report · Aug 1, 2026
Cleveland Clinic and IBM Researchers Create Quantum Machine Learning Framework to Predict Neoantigen Immune Response
The Quantum Insider · Jul 30, 2026
Cleveland Clinic and IBM researchers create quantum machine learning framework to predict neoantigen immune response
eurekalert.org · Jul 30, 2026
Cleveland Clinic, RIKEN and IBM Team Advance to Finals for 2026 ACM Gordon Bell Prize
IBM · Sep 9, 2026